$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Delivery means for biologically active agents 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C08G-018/48
  • A61K-009/02
  • A61K-031/557
  • A61K-031/785
출원번호 US-0044213 (1979-05-31)
우선권정보 GB-0051917 (1976-12-13); AU-0031065 (1977-11-30); PK-0000436 (1977-11-30)
발명자 / 주소
  • Fildes Francis J. T. (Macclesfield GB2) Hutchinson Francis G. (Macclesfield GB2)
출원인 / 주소
  • Imperial Chemical Industries Limited (London GB2 03)
인용정보 피인용 횟수 : 48  인용 특허 : 2

초록

A sustained release delivery means comprising a biologically active agent and a hydrophilic linear block poly oxyalkylene- polyurethane copolymer.

대표청구항

The sustained release delivery means comprising: (a) a functionally effective amount of a biologically active agent; and (b) a hydrophilic linear block polyoxyalkylene-polyurethane copolymer of the type ABABAB . . . having blocks A linked to blocks B, substantially devoid of cross-linking, wherein A

이 특허에 인용된 특허 (2)

  1. Hudgin Donald Edward (Princeton Junction NJ) Blair Edgar Allan (Cranbury NJ), Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles.
  2. Lock Peter Maurice (Gillingham EN), Surgical dressings.

이 특허를 인용한 특허 (48)

  1. Lee Chi-Long (Midland MI) Ulman Katherine L. (Sanford MI), Adhesive compositions, controlled release compositions and transdermal delivery device.
  2. Shikinami Yasuo (Osaka JPX) Sasatani Seiei (Osaka JPX), Adhesive for percutaneous administration.
  3. Aniuk Lawrence M. (Santa Clara CA) Dieck Ronald L. (Irving CA) Hardy Dwayne (San Mateo CA), Assembly for adminstering IV solution.
  4. Nicolson, Donald Magnus; Halliday, Janet Anne; Tuominen, Jukka; Zurutuza, Amaia, Bioresorbable polymers.
  5. Lee, Chi-Long; Ulman, Katherine L., Controlled release compositions and transdermal drug delivery device.
  6. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark Alexander; Halliday, Janet Anne, Hydrophilic polyurethane compositions.
  7. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark; Halliday, Janet Anne, Hydrophilic polyurethane compositions.
  8. Lorenz, Donald H., Hydrophilic, flexible, open cell polyurethane-poly(N-vinyl lactam) interpolymer foam and dental and biomedical products fabricated therefrom.
  9. Lee Chi-Long (Midland MI) Gornowicz Gerald A. (Midland MI), Matrix for release of active ingredients.
  10. Lee Chi-Long (Midland MI) Gornowicz Gerald A. (Midland MI), Matrix for release of active ingredients.
  11. Grainger David J. (Cambridge GB2) Metcalfe James C. (Cambridge GB2), Method for identifying an agent which increases TGF-beta levels.
  12. David J. Grainger GB; Paul R. Kemp GB, Method to determine TGF-.beta..
  13. Grainger,David J.; Kemp,Paul R., Method to determine TGF-beta.
  14. Reich Murray H. (Princeton NJ) Nelson Ken (Lambertville NJ) Kuzma Jirina (Princeton NJ), Polyether polyurethane polymers and gels having improved absorption and slip properties.
  15. Aniuk Lawrence M. (Santa Clara CA) Dieck Ronald L. (Irving CA) Hardy Dwayne (San Mateo CA), Polymeric article having high tensile energy to break when hydrated.
  16. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark; Halliday, Janet A., Polyurethane elastomers.
  17. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark; Halliday, Janet Anne, Polyurethane elastomers.
  18. Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GB2, Prevention and treatment of cardiovascular pathologies.
  19. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GBX, Prevention and treatment of cardiovascular pathologies.
  20. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of cardiovascular pathologies.
  21. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kunz Lawrence L. ; Schroff Robert W., Prevention and treatment of cardiovascular pathologies with tamoxifen analogues.
  22. Grainger David J. (Cambridge GBX) Metcalfe James C. (Cambridge GBX) Weissberg Peter L. (Cambridge GBX), Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  23. Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  24. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  25. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  26. Bruck, Stephen D., Rate-controlled drug release system.
  27. Robertson, Steven, Stabilised prostaglandin composition.
  28. Robertson, Steven, Stabilised prostaglandin composition.
  29. Robertson, Steven, Stabilised prostaglandin composition.
  30. Alt, Eckhard, Stent device and method.
  31. Nuwayser Elie S. (Wellesley MA), Sustained release composition.
  32. Kunz Lawrence L., Therapeutic inhibitor of vascular smooth muscle cells.
  33. Kunz Lawrence L. ; Klein Richard A. ; Reno John M., Therapeutic inhibitor of vascular smooth muscle cells.
  34. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2 ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  35. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  36. Kunz Lawrence L. ; Reno John M., Therapeutic inhibitor of vascular smooth muscle cells.
  37. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  38. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  39. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  40. Kunz, Lawrence L.; Klein, Richard A.; Reno, John M., Therapeutic inhibitor of vascular smooth muscle cells.
  41. Kunz, Lawrence L.; Reno, John M., Therapeutic inhibitor of vascular smooth muscle cells.
  42. Kunz, Lawrence L.; Reno, John M., Therapeutic inhibitor of vascular smooth muscle cells.
  43. Lawrence L. Kunz ; John M. Reno, Therapeutic inhibitor of vascular smooth muscle cells.
  44. Lawrence L. Kunz ; Richard A. Klein ; John M. Reno, Therapeutic inhibitor of vascular smooth muscle cells.
  45. Jost Leonora (R.R. 1 ; Box 130 Oxford ME 04270), Transdermal and transmucosal vortexed foam devices and the method of making.
  46. Halliday, Janet A.; Tuominen, Jukka; Livingstone, Mark; Koppenhagen, Frank; Currie, Lilias; Stewart, Sarah, Water-swellable polymers.
  47. Halliday, Janet A.; Tuominen, Jukka; Livingstone, Mark; Koppenhagen, Frank; Currie, Lilias; Stewart, Sarah, Water-swellable polymers.
  48. Halliday, Janet Anne; Tuominen, Jukka; Livingstone, Mark Alexander; Koppenhagen, Frank; Currie, Lilias Morton; Stewart, Sarah, Water-swellable polymers.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로